Lin M, Huo M, Zhao X
Zhonghua Xue Ye Xue Za Zhi. 2023; 43(7):608-611.
PMID: 36709142
PMC: 9395567.
DOI: 10.3760/cma.j.issn.0253-2727.2022.07.015.
Wang A, Li W, Zhao F, Zheng Z, Yang T, Wang S
Cell Transplant. 2022; 31:9636897221102902.
PMID: 35670196
PMC: 9178980.
DOI: 10.1177/09636897221102902.
Rovatti P, Gambacorta V, Lorentino F, Ciceri F, Vago L
Front Immunol. 2020; 11:147.
PMID: 32158444
PMC: 7052328.
DOI: 10.3389/fimmu.2020.00147.
Chen D, Qi M
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020; 48(5):560-566.
PMID: 31901032
PMC: 8800777.
DOI: 10.3785/j.issn.1008-9292.2019.10.15.
Walker C, Kohlschmidt J, Eisfeld A, Mrozek K, Liyanarachchi S, Song C
Clin Cancer Res. 2019; 25(21):6524-6531.
PMID: 31375516
PMC: 6825549.
DOI: 10.1158/1078-0432.CCR-19-0725.
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.
Jan M, Leventhal M, Morgan E, Wengrod J, Nag A, Drinan S
Blood Adv. 2019; 3(14):2199-2204.
PMID: 31324640
PMC: 6650729.
DOI: 10.1182/bloodadvances.2019000445.
Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia.
Lundin-Strom K, Biloglav A, Lilljebjorn H, Rissler M, Fioretos T, Hansson M
Leukemia. 2018; 32(9):2058-2062.
PMID: 29967378
PMC: 6127080.
DOI: 10.1038/s41375-018-0191-0.
Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report.
Venci A, Mazza R, Spinelli O, Di Schiena L, Bettio D
Oncol Lett. 2017; 13(6):4180-4184.
PMID: 28599418
PMC: 5453168.
DOI: 10.3892/ol.2017.5979.
SNP Array in Hematopoietic Neoplasms: A Review.
Song J, Shao H
Microarrays (Basel). 2016; 5(1).
PMID: 27600067
PMC: 5003446.
DOI: 10.3390/microarrays5010001.
The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.
Canham M, Van Deusen A, Brison D, De Sousa P, Downie J, Devito L
Sci Rep. 2015; 5:17258.
PMID: 26607962
PMC: 4660465.
DOI: 10.1038/srep17258.
Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?.
Hamdi A, Cao K, Poon L, Aung F, Kornblau S, Fernandez Vina M
Bone Marrow Transplant. 2015; 50(3):411-3.
PMID: 25621795
PMC: 4807113.
DOI: 10.1038/bmt.2014.285.
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.
Crucitti L, Crocchiolo R, Toffalori C, Mazzi B, Greco R, Signori A
Leukemia. 2014; 29(5):1143-52.
PMID: 25371177
DOI: 10.1038/leu.2014.314.
Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results.
Hemmat M, Chen W, Anguiano A, Naggar M, Racke F, Jones D
Mol Cytogenet. 2014; 7:35.
PMID: 25177364
PMC: 4149311.
DOI: 10.1186/1755-8166-7-35.
Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms.
Tang G, Lu X, Wang S, Roney E, Zhang L, Hu S
Int J Clin Exp Pathol. 2014; 7(6):3196-201.
PMID: 25031740
PMC: 4097224.
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.
Klampfl T, Milosevic J, Puda A, Schonegger A, Bagienski K, Berg T
PLoS One. 2013; 8(10):e77819.
PMID: 24147083
PMC: 3797696.
DOI: 10.1371/journal.pone.0077819.
Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.
Iacobucci I, Lonetti A, Papayannidis C, Martinelli G
Curr Cancer Drug Targets. 2013; 13(7):791-810.
PMID: 23941516
PMC: 4104470.
DOI: 10.2174/15680096113139990089.
GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
Cazier J, Holmes C, Broxholme J
Bioinformatics. 2012; 28(22):2981-2.
PMID: 22962342
PMC: 3496338.
DOI: 10.1093/bioinformatics/bts547.
Integrated genomic analysis of sézary syndrome.
Mao X, Chaplin T, Young B
Genet Res Int. 2012; 2011:980150.
PMID: 22567373
PMC: 3335609.
DOI: 10.4061/2011/980150.
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.
Kuhn M, Radtke I, Bullinger L, Goorha S, Cheng J, Edelmann J
Blood. 2012; 119(10):e67-75.
PMID: 22234698
PMC: 3311263.
DOI: 10.1182/blood-2011-09-380444.
CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.
Haferlach C, Bacher U, Kohlmann A, Schindela S, Alpermann T, Kern W
Haematologica. 2011; 96(6):829-36.
PMID: 21422114
PMC: 3105644.
DOI: 10.3324/haematol.2010.035584.